1. Home
  2. GABC vs NVCR Comparison

GABC vs NVCR Comparison

Compare GABC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

N/A

Current Price

$49.59

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Logo NovoCure Limited

NVCR

NovoCure Limited

N/A

Current Price

$17.89

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GABC
NVCR
Founded
1910
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
GABC
NVCR
Price
$49.59
$17.89
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$47.67
$28.08
AVG Volume (30 Days)
133.2K
1.2M
Earning Date
04-27-2026
04-30-2026
Dividend Yield
2.88%
N/A
EPS Growth
8.13
21.79
EPS
1.90
N/A
Revenue
$487,401,000.00
$655,353,000.00
Revenue This Year
$16.78
$7.72
Revenue Next Year
$3.98
$6.74
P/E Ratio
$26.12
N/A
Revenue Growth
37.80
8.28
52 Week Low
$37.19
$9.82
52 Week High
$52.23
$21.45

Technical Indicators

Market Signals
Indicator
GABC
NVCR
Relative Strength Index (RSI) 51.72 52.55
Support Level $49.23 $14.84
Resistance Level $51.97 $18.37
Average True Range (ATR) 0.92 0.74
MACD -0.26 0.01
Stochastic Oscillator 40.89 56.48

Price Performance

Historical Comparison
GABC
NVCR

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: